BOSTON SCIENTIFIC CORP — Director's Dealing 2013

Feb 14, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2013-02-12

Reporting Person: Pierce David A (SVP and President, Endoscopy)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-02-12	Common Stock	M	3214.0000	$0.0000	Acquired	14173.0000	Direct
2013-02-12	Common Stock	F	1219.0000	$7.5900	Disposed	12954.0000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-02-12	Deferred Stock Units	$0.0000	M	3214.0000	Disposed	2018-02-12	Common Stock (3214.0000)	Direct

Footnotes

F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2: The award vests in five equal annual installments commencing on February 12, 2009, the first anniversary of the date of grant.